A disease-specific iPS cell resource for studying rare and intractable diseases

Area of Science:

• Stem Cell Biology
• Genetics
• Rare Diseases

Background:

• Disease-specific induced pluripotent stem cells (iPSCs) are crucial for studying rare diseases.
• Establishing and banking iPSCs from patients can overcome resource limitations for rare disease research.
• This study aimed to expand the repository of iPSCs derived from patients with intractable diseases in Japan.

Purpose of the Study:

• To comprehensively establish and characterize induced pluripotent stem cells (iPSCs) from patients with designated intractable diseases.
• To create a valuable resource for the research community to facilitate rare disease studies.
• To evaluate the properties of newly generated iPSC lines.

Main Methods:

• Recruitment of patients with designated intractable diseases and collection of blood samples.
• Establishment of iPSCs using the episomal method.
• Deposit of established iPSC clones into a cell bank for accessibility.

Main Results:

• Successfully established 1,532 iPSC clones from 259 patients across 139 distinct intractable diseases.
• iPSC establishment efficiency was consistent across different ages and sexes.
• All iPSC clones expressed key pluripotency markers OCT3/4 and NANOG, confirming their stem cell identity.

Conclusions:

• The newly established iPSC lines represent a significant and readily available resource for researchers.
• These iPSCs will aid in pathological analysis, diagnosis, and the development of therapeutic strategies for rare intractable diseases.
• This initiative enhances the global capacity for rare disease research by providing critical cellular models.